New Flu Vaccine to Offer Better Protection

The two additional influenza strains are expected to be added to the vaccine in 2013.
Every year the Food and Drug Administration decides which strains of influenza should be included in the next flu vaccine. An FDA advisory panel recently recommended keeping one of the current strains and adding two new strains of influenza to the vaccine. The decision was based on trends and strains being seen other places in the world, such as the Southern Hemisphere.
However, it’s a new vaccine that has captured the attention of many, one that could offer better protection against more strains of the virus.
The new FluMist Quadrivalent will add an additional strain of influenza B to the vaccine. It’s the first flu vaccine to offer protection against four different strains of influenza.
“The current flu vaccine protects against three strains of the virus, two types of influenza A and one type of influenza B,” said Todd Bell, M.D., executive director of the West Texas Influenza Center.
“If you only protect against one strain of the virus, there’s a chance you’ll get the flu from another strain,” Bell said. “The idea of adding another strain of influenza B increases our chances of protection.”
The new vaccine isn’t expected to be available until 2013.
“For one, production of the next year’s vaccine is probably already under way,” Bell said. “Also, they still have to determine which strain of influenza B to include in the new vaccine.”
Each year, flu infections are associated with more than 100,000 hospitalizations and more than 10,000 deaths either directly from the flu or other causes including respiratory and circulatory complications
Bell said it’s important that people get their flu shots, regardless of which strains or how many are included in the vaccine.
“The key thing is that people need to get their flu shots,” he said. “If they do, we’ll save lives in the U.S.”
Related Stories
Willed Body Memorial Service Honors Those Who Donated
On Memorial Day each May, a service is conducted at the Texas Tech University Health Sciences Center Institute of Anatomical Sciences to pay respect to the Willed Body Program donors and their families.
Molecular Pathology Preceptorship: Unmatched Value and Experience
Ericka Hendrix, PhD, MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions spoke about the program’s preceptorship.
Moseley Named Permian Basin Regional Dean of the Texas Tech University Health Sciences Center School of Nursing
Kelly Moseley, DHSc, R.N., has been named the TTUHSC School of Nursing regional dean in the Permian Basin.
Recent Stories
TTUHSC Researchers to Study Gene’s Role in Prostate Cancer Metastasis
With support from a three-year, $1.85 million grant, Srinivas Nandana, Ph.D., and co-investigator Manisha Tripathi, Ph.D., from the Department of Cell Biology and Biochemistry at the TTUHSC School of Medicine will investigate the role of TBX2.
TTUHSC Professor and Surgeon Receives National Award
The American Burn Association (ABA) recently presented the prestigious Lifetime Achievement Award to TTUHSC professor and burn surgeon John A. Griswold, M.D.
TTUHSC Researcher Receives National Award
The AACR presented its Minority-Serving Institution Faculty Scholar in Cancer Research Award to TTUHSC Associate Professor Duke Appiah, Ph.D., MPH, at the AACR 2025 Annual Meeting in Chicago recently.